Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy - Wikidata - awgldk - TriplyDB

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

http://www.wikidata.org/entity/Q37042355

about

25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives Optimal combination of antiangiogenic therapy for hepatocellular carcinoma New approaches for precise response evaluation in hepatocellular carcinoma Transcatheter embolization therapy in liver cancer: an update of clinical evidences Prognostication and response assessment in liver and pancreatic tumors: The new imaging Assessment of response to therapy in hepatocellular carcinoma Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: a pilot study.Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging for Monitoring the Early Response to ZD6474 from Nasopharyngeal Carcinoma in Nude Mouse.Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.Role of quantitative magnetic resonance imaging parameters in the evaluation of treatment response in malignant tumors.Targeting the tumor stroma in hepatocellular carcinoma.Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.

P2860

Q26774810-77CC7489-8B69-4F3F-9DAF-02D82E202FD7 Q26799458-DA225D1B-9C5A-455E-B876-C0763ABE33B7 Q26866367-98D879F1-CAEB-4147-93CF-908F9F2C4668 Q27003849-443EED81-3CCE-404E-9DD1-FAC833514654 Q27021568-6BEB5DC3-C783-4B9A-8C2E-3834A72EC053 Q33560982-177FD198-C93E-457F-9486-ABE3EEC45348 Q34229404-95C878A2-E7C2-4AF7-BF5B-E90F33B3E3A6 Q35196265-16422ACE-DC9C-4D96-8320-C03060B02284 Q35568722-7E5EA406-AF53-4CA4-8A4E-3252DCAD329E Q35762255-629261B1-45E4-4768-9170-8337B910C45B Q35772492-519B28DB-D614-4ACA-911E-A6C3D7405749 Q36287670-C73E4D6F-DE1C-41C1-9963-FC85840A916B Q36747536-CB2287CA-B2AB-4D12-9FAC-D9AC7FAE5092 Q36801476-E528963E-562F-4481-BDDE-5BAA8716CA0B Q38366586-810F93C5-DF3A-451B-9119-3177B22BB990 Q39044851-56DBE341-EC50-4546-90CB-6209257FFC24

P2860

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy

http://www.wikidata.org/entity/Q37042355

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Magnetic resonance imaging bio ...... arkers after sunitinib therapy

@en

Magnetic resonance imaging bio ...... rkers after sunitinib therapy.

@nl

type

label

Magnetic resonance imaging bio ...... arkers after sunitinib therapy

@en

Magnetic resonance imaging bio ...... rkers after sunitinib therapy.

@nl

prefLabel

Magnetic resonance imaging bio ...... arkers after sunitinib therapy

@en

Magnetic resonance imaging bio ...... rkers after sunitinib therapy.

@nl

P1433

Q37042355-FFDA8C7A-AC8E-4986-8454-8F28A058A57F

P1476

Q37042355-758FE313-E87C-4EA6-A97D-202460405183

P2093

Q37042355-05603BF7-8B67-44E6-9179-00EF3956459F

Q37042355-692BA6C3-0197-413B-A015-6A93D408E95A

Q37042355-790033FA-2AF1-456D-9626-8BE751A33401

Q37042355-895F6320-8E8C-4FCD-BDDC-22DBBFDED8F8

Q37042355-8A1CFCCB-8CC0-42EF-AC8D-CE203912503E

Q37042355-8A58FE55-035E-43E3-A691-1DE2914EA6E3

Q37042355-B5D078ED-8D4F-42AB-B799-FA5454AD6DDF

Q37042355-F2AFE7D4-38A0-4CE4-A68A-3444DBD53248

P2860

Q37042355-05D13B04-E09E-4B26-9B0F-7C6403D1A0EE

Q37042355-065F0920-007A-4B11-A704-BFCC29587FF5

Q37042355-07D30481-EB5B-45A7-BFEF-08FFDD775A29

Q37042355-0E9CE6BC-F9CB-4998-B571-23E3A7856E7B

Q37042355-122C69C3-92B3-4899-8814-87578873B10F

Q37042355-135B1753-1326-42BA-AA42-5000A08423DA

Q37042355-144D52B2-66AF-4C03-B40E-41CFFD0FA030

Q37042355-16016978-DE15-4248-BFAE-C7903CA8FF13

Q37042355-1B31ED54-E46A-4987-9304-2C210033E115

Q37042355-1C9DB977-ECC9-408A-8783-F60B395C0F5A

P2888

Q37042355-3FF733EF-4037-459C-8AF7-D8AC8CEA70B6

P304

Q37042355-695006C6-BD00-41AC-9FEB-29BC752F56F4

P31

Q37042355-B3E31DAD-F6E6-417A-B60E-0CF5282A2C12

P356

Q37042355-755CDB8A-81AD-48CA-B158-125C0AD0A3D5

P478

Q37042355-2D973541-6270-40E7-9665-7B76CA88DDAA

P577

Q37042355-59DC854E-73A8-43CE-958E-242FCE861175

P5875

Q37042355-1F859C4F-738A-4003-BCA4-6265A3EFAB0C

P6179

Q37042355-DBC4482D-2F35-4480-8A91-8FBCF52B77CE

P698

Q37042355-CE88DF11-94FA-4912-848D-F46CAF7E39A2

P921

Q37042355-08695C88-2746-4725-96BC-4ECEB3BB20AD

P932

Q37042355-576B2F2A-1A5B-4FF6-8ACB-B526A2DF0280

P356

P1433

Journal of Hematology & Oncology

P1476

Magnetic resonance imaging bio ...... arkers after sunitinib therapy

@en

P2093

Andrew X Zhu

http://www.w3.org/2001/XMLSchema#string

Dan G Duda

http://www.w3.org/2001/XMLSchema#string

Dushyant V Sahani

http://www.w3.org/2001/XMLSchema#string

Koichi Hayano

http://www.w3.org/2001/XMLSchema#string

Marek Ancukiewicz

http://www.w3.org/2001/XMLSchema#string

Onofrio A Catalano

http://www.w3.org/2001/XMLSchema#string

Rakesh K Jain

http://www.w3.org/2001/XMLSchema#string

Tao Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Molecular mechanisms and clinical applications of angiogenesis

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study.

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization

P2888

P304

51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-8722-6-51

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248396436

http://www.w3.org/2001/XMLSchema#string

P6179

1021830255

http://www.w3.org/2001/XMLSchema#string

P698

23842041

http://www.w3.org/2001/XMLSchema#string

P921

P932

3722053

http://www.w3.org/2001/XMLSchema#string